Clinical evaluation of moxalactam.
We investigated the clinical efficacy of moxalactam for treatment of a variety of infectious disorders in 50 patients (38 males and 12 females). Patient ages ranged from 8 days to 98 years, with a median of 66 years. Infectious disorders were confirmed by isolation of etiological bacteria in all pat...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1981
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181638/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6456688/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.1.88 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|